Monitoring Methods for Pancreatic Cyst
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to compare the two approaches for monitoring pancreatic cysts. The study doctors want to compare more frequent monitoring vs less frequent monitoring in order to learn which monitoring method leads to better outcome for patients with pancreatic cysts.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is the monitoring method for pancreatic cysts safe for humans?
Endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) are generally considered safe for evaluating pancreatic cysts, although there are some conflicting data about complication rates. Computed tomography (CT) and magnetic resonance imaging (MRI) are non-invasive imaging techniques that are widely used and considered safe for monitoring pancreatic cysts.12345
Is the monitoring of pancreatic cysts using CT scans, EUS, and MRI generally safe?
How does this treatment for pancreatic cysts differ from other treatments?
This treatment uses advanced imaging techniques like CT scans, MRIs, and endoscopic ultrasound (EUS) to monitor pancreatic cysts, which helps in better risk assessment and diagnosis. EUS is particularly useful as it allows for high-resolution imaging and the ability to sample cyst fluid for analysis, which can help detect early signs of cancer.12789
How does the treatment for monitoring pancreatic cysts differ from other treatments?
This treatment uses advanced imaging techniques like CT scans, MRIs, and endoscopic ultrasound (EUS) to monitor pancreatic cysts, which is unique because it combines non-invasive and minimally invasive methods to provide detailed images and fluid analysis, helping to better assess the risk of malignancy compared to traditional methods.12789
What data supports the effectiveness of this treatment for monitoring pancreatic cysts?
What data supports the effectiveness of the treatment for monitoring pancreatic cysts?
Advanced imaging techniques like CT scans and MRIs, along with endoscopic ultrasound (EUS), are effective in evaluating pancreatic cysts. These methods help in risk stratification and diagnosis, improving the detection and characterization of cysts, which is crucial for early intervention and management.1271011
Who Is on the Research Team?
David S Weinberg
Principal Investigator
ECOG-ACRIN Cancer Research Group
Are You a Good Fit for This Trial?
This trial is for people aged 50-75 with pancreatic cysts larger than 1 cm, discovered in the last 6 months. It's not for those who are pregnant, have acute or chronic pancreatitis, a history of pancreatic cancer, specific low-risk lesions, family history of certain cancers, cyst features indicating surgery need, serious illnesses preventing surgery or current participation in other cyst monitoring.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Imaging
Patients undergo MRI or CT at the beginning of the trial
Surveillance
Patients are monitored with MRI or CT based on cyst size and arm assignment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Computed Tomography
- Endoscopic Ultrasound
- Magnetic Resonance Imaging
- Quality-of-Life Assessment
- Questionnaire Administration
Computed Tomography is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
ECOG-ACRIN Cancer Research Group
Lead Sponsor
National Cancer Institute (NCI)
Collaborator